Search

Gleneagle targets biotech

Gleneagle Gold will make a second attempt at a reverse takeover with plans to buy a local unlisted medical cannabis company in a deal worth about $8 million.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Included in the following lists:

Share Transactions

30/06/15
$0 Other
30/06/15
$0 Other
30/06/15
$0 Other
Total value as at the date of the transaction
Source: Morningstar

BNiQ Disclaimer